Services
The Plexus Edge
Plexus’ clients come to us to discuss their strategic objectives and augment their capabilities to manage long and time-consuming transactions that would direct internal resources away from important activities. The following factors are what determines the Plexus’ advantage.
Network
We interact with key decision makers at healthcare companies of all sizes worldwide on a daily basis to discuss our broad portfolio of projects. We know them and they know Plexus.
Credibility
Companies react to Plexus’ projects as they trust the “reverse due diligence” we perform to assess the validity of a project.
Transaction Excellence
We bring structure into opportunistic and unstructured corporate and business development activities to achieve objectives quickly and with the best possible outcome offered by the market at a given time.
The Plexus Edge
Plexus’ clients come to us to discuss their strategic objectives and augment their capabilities to manage long and time-consuming transactions that would direct internal resources away from important activities. The following factors are what determines the Plexus’ advantage.
Network
We interact with key decision makers at healthcare companies of all sizes worldwide on a daily basis to discuss our broad portfolio of projects. We know them and they know Plexus.
Credibility
Companies react to Plexus’ projects as they trust the “reverse due diligence” we perform to assess the validity of a project.
Transaction Excellence
We bring structure into opportunistic and unstructured corporate and business development activities to achieve objectives quickly and with the best possible outcome offered by the market at a given time.
Mergers & Acquisitions
Our experience provides our clients with the expertise needed to obtain new sources of revenue growth, whether this be expanding an existing portfolio or diversifying into new areas of the market. At all stages of the process, we take advantage of our global network to meet our clients’ business objectives, working together to identify potential acquisitions and negotiate multinational deals. We help our clients with an assessment of valuation, identification of critical factors, creatively deal design and negotiation of complex agreements.
Asset Divestments
We are experts in divestments. Our extensive experience is built over decades of organizing divestiture deals on behalf of large corporations, private equity funds and entrepreneurs. Our track record of successful divestment transactions on behalf of our clients exists thanks to our skill in identifying, analysing, and targeting potential buyers, framing the opportunity, negotiating definitive agreements, and successfully managing deals no matter how challenging the timetable.
Licensing & Partnerships
Plexus Ventures’ proven process encompasses the entire transaction, from early assessment to deal completion, helping clients identify and evaluate collaboration opportunities. We generate a list of prospective partners, initiate contacts, and advance discussions with interested companies using our network of core decision makers. By creating competition, we work to increase transactional value and obtain feedback to maximize potential. We have helped companies create sustained strategic partnerships through the successful in- and out-licensing of technologies, compounds, and products at all stages of development.
Consulting
Plexus Ventures applies its extensive industry knowledge and consulting experience to address strategic questions of biotech CEO/CBOs: Is our asset ready for partnering? What can we anticipate for deal terms? Is our technology sufficiently differentiated from the perspective of potential partners? Plexus offers a Strategic Licensing Assessment (SLA) to address these and similar concerns, often before committing to running a formal partnering process. We have conducted SLAs for mRNA delivery, CDMO services, positioning of an animal-free therapeutic, and others. A valuable feature of the SLA is our contacting of potential partners to fine-tune our recommendations.